Hui Sheng Biological (300871.SZ) released its performance for the first half of the year, with a net profit attributable to the parent company of 206 million yuan, a year-on-year increase of 75.59%.

Zhizhong Finance APP news, Huisheng Biology (300871.SZ) released its semi-annual report for 2026. During the reporting period, the company achieved an operating revenue of 865 million yuan, a year-on-year increase of 5.20%. The net profit attributable to shareholders of the listed company reached 206 million yuan, a year-on-year increase of 75.59%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 142 million yuan, a year-on-year increase of 43.26%. The basic earnings per share was 1.0169 yuan.